JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Penumbra Inc

Slēgts

SektorsVeselības aprūpe

252.52 -0.37

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

252.26

Max

255.58

Galvenie mērījumi

By Trading Economics

Ienākumi

6M

45M

Pārdošana

15M

339M

P/E

Sektora vidējais

65.335

37.461

Peļņas marža

13.336

Darbinieki

4,500

EBITDA

1.9M

51M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+20.25% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 5. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

797M

9.7B

Iepriekšējā atvēršanas cena

252.89

Iepriekšējā slēgšanas cena

252.52

Ziņu noskaņojums

By Acuity

100%

0%

357 / 373 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

Penumbra Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 26. okt. 23:52 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 26. okt. 23:52 UTC

Tirgus saruna

Nikkei May Rise on Weaker Yen -- Market Talk

2025. g. 26. okt. 23:46 UTC

Tirgus saruna

Oil Rises Amid Ongoing Supply Concerns -- Market Talk

2025. g. 26. okt. 23:41 UTC

Tirgus saruna

Gold Falls; U.S.-China Trade Deal Optimism Overcomes Signs of Cooler U.S. Inflation -- Market Talk

2025. g. 26. okt. 23:34 UTC

Peļņas

Sinopharm Group 9-Mos Oper Pft CNY10.87B Vs. Pft CNY10.84B >1099.HK

2025. g. 26. okt. 23:32 UTC

Peļņas

Sinopharm Group 9-Mos Net CNY5.31B Vs. Net CNY5.28B >1099.HK

2025. g. 26. okt. 23:30 UTC

Peļņas

Sinopharm Group 9-Mos Rev CNY431.48B Vs. CNY442.42B >1099.HK

2025. g. 26. okt. 22:29 UTC

Peļņas

WuXi AppTec 3Q Rev CNY12.06B ; up 15.3% on Year>603259.SH

2025. g. 26. okt. 22:29 UTC

Peļņas

WuXi AppTec: Higher Contributions From Contract Research Development and Manufacturing Organization Unit Supported Results>603259.SH

2025. g. 26. okt. 22:29 UTC

Peļņas

WuXi AppTec: Results Also Boosted From Divestment Gains >603259.SH

2025. g. 26. okt. 22:29 UTC

Peļņas

WuXi AppTec 3Q Net CNY5.13B ; up 82.9% on Year>603259.SH

2025. g. 26. okt. 22:16 UTC

Peļņas

Stock Futures Rise Ahead of Mag 7 Earnings, Fed Decision -- Barrons.com

2025. g. 26. okt. 21:33 UTC

Iegādes, apvienošanās, pārņemšana

Novartis Agrees to Acquire Avidity Biosciences for $12 Billion -- WSJ

2025. g. 26. okt. 19:29 UTC

Iegādes, apvienošanās, pārņemšana

Novartis Deal Values Avidity Biosciences At $12 Billion -- Barrons.com

2025. g. 26. okt. 06:39 UTC

Peļņas

CITIC Securities 3Q Rev CNY22.78B Vs. CNY15.96B >6030.HK

2025. g. 26. okt. 06:39 UTC

Peļņas

CITIC Securities: Higher Income From Brokerage, Investment Banking Supported Results>6030.HK

2025. g. 26. okt. 06:39 UTC

Peļņas

CITIC Securities 3Q Net CNY9.44B Vs. Net CNY6.23B >6030.HK

2025. g. 24. okt. 21:24 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 24. okt. 21:24 UTC

Tirgus saruna

Moody's Sees France With Increased Risk of Political Dysfunction -- Market Talk

2025. g. 24. okt. 21:07 UTC

Peļņas

The Score: Netflix, Amazon.com, Six Flags and More Stocks That Defined the Week -- WSJ

2025. g. 24. okt. 20:58 UTC

Peļņas

S&P 500 Climbs to New Record on Strong Earnings -- WSJ

2025. g. 24. okt. 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 24. okt. 20:40 UTC

Peļņas

Intel Expects Chip Shortages on Better PC Demand. Here's Why AMD Is Winning Too. -- Barrons.com

2025. g. 24. okt. 20:24 UTC

Peļņas

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

2025. g. 24. okt. 20:23 UTC

Peļņas

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

2025. g. 24. okt. 20:13 UTC

Peļņas

These Stocks Moved the Most Today: Intel, AMD, Ford, Deckers, Newmont, Nextracker, Booz Allen, Coinbase, and More -- Barrons.com

2025. g. 24. okt. 20:07 UTC

Tirgus saruna

Different-Cell Imputation Rose Proportionally in September CPI -- Market Talk

2025. g. 24. okt. 19:40 UTC

Tirgus saruna

Treasury Yields Mixed, Dollar Stronger Ahead of Fed Week -- Market Talk

2025. g. 24. okt. 19:35 UTC

Tirgus saruna

Oil Rally on U.S. Russia Sanctions Loses Steam -- Market Talk

2025. g. 24. okt. 19:33 UTC

Peļņas

IBM and Google Are Also Making Moves in Quantum. Don't Count Out the Bigger Players. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Penumbra Inc Prognoze

Cenas mērķis

By TipRanks

20.25% augšup

Prognoze 12 mēnešiem

Vidējais 304.21 USD  20.25%

Augstākais 350 USD

Zemākais 265 USD

Pamatojoties uz 16 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Penumbra Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

16 ratings

13

Pirkt

3

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

288.28 / 292.9394Atbalsts un pretestība

Īstermiņā

Bearish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bullish Evidence

Noskaņojums

By Acuity

357 / 373 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat